Beta-adrenergic blocking drugs have progressively become more widely used since their introduction in the mid-1960's. Their importance to anaesthetists lies in their ability to modify the normal responses to anaesthetic agents and to the stresses encountered during surgery. Anaesthetists are concerned with betablockers in two basic situations. The first situation occurs when a decision has to be made preoperatively whether or not to continue medication during anaesthesia in a patient already taking one of these drugs. The second is during anaesthesia when the initiation of beta-adrenergic blockade may be desirable. A knowledge of the basic pharmacology of these drugs and their interaction with anaesthetic agents will resolve many problems which may arise in a clinical situation.
BASIC PHARMACOLOGY
Propranolol can be regarded as the prototype beta-adrenergic blocking drug, and its actions are well known (Nickerson 1970) . The other beta-blockers currently in use can have their pharmacological properties described relative to those of propranolol. The main effects of propranolol, from the anaesthetic viewpoint, are on the cardiovascular system. In addition to its beta-hlockade, propranolol h'3.s a direct effect on cell membranes that is characteristic of local anaesthetics and quinidine, resulting in anti-arrhythmic properties.
Propranolol decreases heart rate, reduces cardiac output and/or peripheral resistance (depending on compensatory reflexes) and reduces myocardial contractility. All these effects are' more marked under conditions of increased demand and sympathetic tone, but still occur at rest (Price et al. 1967) . Inhibition of cardiac arrhythmias can be due to the quinidine-like action, although in certain situations such as adrenaline-halothane arrhythmias beta-blockade is the specific mechanism of action (Sharma 1969).
Propranclol increases airway resistance, and this is potentially dangerous in asthmatics. Tlle cell membrane effect can result in potentiation of curare blockade at the neuromuscular junction.
Dogs anaesthetized with halothane lose their ability to maintain an adequate cardiac output following haemorrhage when they are given propranolol (Weis and Brackebuscb 1970) . These falls in cardiac output are not reflected by blood pressure changes, indicating that blood pressure measurement is not a reliable index on which to base conclusions about cardiac function. The increase in cardiac output which normally occurs during halothane anaesthesia as the arterial carbon dioxide tension rises is abolished by beta-receptor blockade (Norman and Atkinson 1970) .
The newer beta-adrenergic receptor blockers differ in some of their actions (Fitzgerald 1969) . Briefly, alprenolol and oxprenolol have a less marked negative inotropic action, perhaps due to a sympathomimetic effect, but still have some quinidine-like properties and bronchospasm can occur.
Practolol appears to be cardioselective, blocking beta-1 receptors (Dunlop and Shanks 1968) and causes no problems in asthmatics. It has no quinidine-like activity and is less myocardial depressant than prepranolol. Table 1 shows the rebtive properties of the currently available beta-adrenergic blocking drugs. Despite the differences between propranolol and the newer agents, cardiac output during halothane anaesthesia is still reduced by oxprenolol, alprenolol and practolol (Stephen et al. 1971) . It should be noted that in all these cases the reduction in output is in part due to a reduction in heart rate and in part due to a reduction in stroke volume. Thus in clinical practice, to keep the decrease in cardiac output to a minimum, atropine (0'01-0'02 mg/kg) should be given intravenously to block any increase in vagal tone which would othervvise slow the heart rate excessively. Patients with a wide variety of disease states are currently treated with heta-hlockers. These include cardiac arrhythmias, angina pectoris, ohstructive cardiomyopathy, Fallot's tetralogy as well as hypertension, thyrotoxicosis and phaeochromocvtoma.
Some patients with parkinsonism and glaucoma arc also treated with heta-blockers.
Since beta-b]ockers Illay interfere with Ilormal responses tn anaesthesia' and surgical stress, it becomes ne cess an' to decide which patients arc placeo at greater risk 1)\' remaining on their therap~' and w!Jich patients ahsoluteh' require continuation of their beta-blockade.
A lI{',illa Pectoris
H.elid from angina is obtained b~' hlocking the response of the heart to snnpathetic stimulation, thus preventing the increase in heart rate and \·elocit\· of ventricular contraction which has been c()rrelaterl wit h the onset of angina (Dwyer et al. ] !)(j8). It is the ;l1lthor's practice to cease beta-blockers in these patients two da\'s pre-output, should there 11l' any increase in vagal tone.
(2) Meticulous care is taken to maintain blood volume. (3) Cardiac depression, e.g. h\' overdose of halothane, is avoided. (4) The patient is digitalized if there lS evidence of cardiac failure.
Card iac A rrh\'tlzIII ias
A decision will need to he made in individual cases as to which is worse---the risk of diminished cardiac function from beta-blockers or the risk of severe arrh:vthmias during anaesthesia.
Hypertcnsio1l
An increasing number of hypertensin' patients arc heing treated with beta-blocker,;. Experience in managing these patients coming to surgery' i,; still limited, but the currl'l1t practice is to continue their treatment and observe the four precautions outlined above. If in indi\'idual cases there is doubt about cardiac resen'e, then cessation of therapy 4S hours preoperatively \muld be justified. operatively, keep the patient at light activity, and use sedation if necessarv. In patients who are to have coronary art en' surger~', betablockers arc ceased a week beforehand, since it is now well recognized that otherwise the heart may not readily restart following cardiopulmonary bypass.
Should a patient managed with a beta-blocking agent come urgently to surgery, the following precautions are observed:
(\) Atropine (0'01-0'0:2 mg/kg) is given intravenously immediately prior to induction. Heart rate will not increase in response to svmpathetic stimulation and lllay slow quite markedly, reducing cardiac Thyrotoxic patients being submitted to thyroidectomy should be clinically euthyroid for approximately one month before surgery and the regime of antithyroid drugs (with the addition of Lugol'S iodine and reserpine, if necessary) is generally effective in establishing euthyroidism (Reeve ] 971). A thyrotoxic patient coming to surgery may in some circumstances require a beta-adrenergic hlocker to minimize the peripheral effects of thyroid on:ractivitv, such as tachycardia, tremor and agitati;m. In these circu111stances it is important to continue the beta-blockade therapv during thyroidectomy and for a week into the post-.·III"t'sllicsi" "lid flltl'lIsivl' Carl', Vut. I. No. 4, Jfay, 1973 operative period to continue to neutralize the peripheral effects of the large circulating thyroxine pool (Pimstone and Joffe 1970). On occasions when beta-blockers have been ceased at the time of surgery in such patients, thyroid storm has threatened post-operatively and has required resumption of blockade (Reeve 1972) .
Phaeochromocytoma
Beta-blockade is now an integral part of the management of these patients pre-operatively and should be continued until tumour removal is complete in order to prevent tachycardia and arrhythmias (Cooperman et al. 1967) . It must be remembered that beta-blockade alone will result in an unopposed vasoconstrictor effect from the tumour, resulting in increased vascular resistance; hence alpha-blockers should always be used in conjunction with beta-blockers (Prichard and Ross 1966) .
Miscellaneous
It would seem prudent to cease, for the period of surgery, beta-blockade in patients with parkinsonism and glaucoma.
INTRA-OPERATIVE INDICATIONS FOR
BETA -BLOCKADE These include thyroid crisis and phaeochromocytoma, arrhythmias during anaesthesia, and abolition of tachycardia during deliberate hypotension.
Arrhythmias during Anaesthesia
Beta-blockers are indicated m potentially dangerous arrhythmias caused by adrenaline overdose or by the use of adrenaline in the presence of halothane. Propranolol in incremental dosage of 1 mg or practolol 2 mg should be used, along with electrocardiographic monitoring.
Similarly, arrhythmias during cardiac surgery many require urgent treatment.
Arrhythmias occurring in the course of otherwise uncomplicated anaesthesia are common and are often diagnosed only with continuous electrocardiographic monitoring. They would not seem to be dangerous (Editorial 1971) since calamities such as ventricular fibrillation or asystole so rarely result. The majority of these arrhythmias disappear spontaneously, respond to increased ventilation or to a reduction in anaesthetic dosage. To treat these arrhythmias with drugs that depress cardiac function appears excessive. Should arrhythmias persist during anaesthesia, the agent of choice for their management is lignocaine, which produces a shorter and less marked fall in cardiac output than do betablockers (Scott et al. 1971) .
Abolition of Tachycardia during Deliberate
Hypotension The use of ganglion blocking agents to produce hypotension during surgery is often complicated by tachycardia due to blockade of the vagal ganglia. Propranolol has been used to abolish this tachycardia (Hewitt et al. 1967) . Although in non-anaesthetized subjects this drug combination does not cause any decrease in cardiac output (Price et al. 1967) , care is required during anaesthesia, and particularly in the presence of halothane.
CONCLUSION

Since
beta-adrenergic blockers depress myocardial function, their use during anaesthesia should be generally restricted to those situations where they are specifically indicated, namely in phaeochromocytoma, thyrotoxicosis, a('renalineinduced arrhythmias and arrhythmias unresponsive to simpler measures. In patients who come to surgery on a beta-blockade regime, atropine to prevent undue bradycardia, adequate blood volume maintenance, and the avoidance of cardiac depression are essential.
